GSK announces completion of the sale of half its stake in Aspen
GlaxoSmithKline (“GSK”) has announced the completion of the disposal of half of its 12.4% shareholding
Filter By:
GlaxoSmithKline (“GSK”) has announced the completion of the disposal of half of its 12.4% shareholding
Aspen’s half-year gross revenue surges by 47% to R19 billion Johannesburg – JSE Limited listed
Aspen is pleased to announce that Aspen Global Incorporated (“AGI”), a wholly owned subsidiary of
Following the announcement of the Anti-Retroviral (ARV) Tender results by the South African National Treasury
Port Elizabeth. The Minister of Trade and Industry, Dr Rob Davies today visited the Aspen
Aspen Holdings is pleased to announce that it has concluded a transaction to acquire a
Aspen Pharmacare Holdings Limited (“Aspen”), listed on the JSE, South Africa (share code APN) and Strides Arcolab Limited, today announced a restructuring of their arrangements
Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded strong returns for the six months ended 31 December 2009. The excellent performance
Johannesburg – Eli Lilly today announced the US$1 million milestone payment to Aspen, South Africa’s leading pharmaceutical manufacturer, as part of the joint collaboration on
Johannesburg – JSE listed Aspen Pharmacare Holdings Limited, Africa’s largest pharmaceutical manufacturer, has produced excellent results for the year ended 30 June 2009. Prevailing global
A message from Aspen Group Chief Executive, Stephen Saad, to the mothers of South Africa’s babies: “At Aspen we understand that the wellbeing of your baby
Johannesburg: Aspen Nutritionals, manufacturer of S-26 and other infant milk formulations (IMFs), confirms that all IMFs manufactured and marketed by Aspen Nutritionals are safe for
OFFICIAL STATEMENT REGARDING THE ALLEGED PURCHASE TRANSACTIONS ENTERED INTO BETWEEN ASPEN AND FRANKEL CHEMICALS FOR THE PURCHASE BY ASPEN FROM FRANKEL CHEMICALS OF RAW MATERIALS
Press Conference Presentation <Click to download> SENS Announcement <Click to download> The Transactions comprise: The acquisition of the rights to distribute GSK products in South
Aspen Holdings
www.aspenpharma.com
Hotline (South Africa)
0800 122 912
Medical Careline (South Africa) 0800 118 088
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com